Taysha Gene Therapies, Inc. (NASDAQ:TSHA) Receives Analysts’ Consensus Recommendation of “Moderate Buy”
According to Bloomberg, the thirteen research firms actively following Taysha Gene Therapies, Inc. (NASDAQ: TSHA) have collectively assigned the stock ...